Tuskan awarded Marcus Wallenberg Prize, forestry’s top honor
91 has launched a program designed to accelerate deployment of innovations that may help fight the COVID-19 pandemic. The COVID-19 Rapid Access Licensing Program will allow companies to license these select technologies at no cost for one year.
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.
Does vaping and smoking e-cigarettes put you at higher risk of COVID-19 complications? UWindsor’s Drew Marquardt is trying to answer that question with research into how the toxicants in the oils of vapes and e-cigarettes affect lung function.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
Scientists have tapped the immense power of the Summit supercomputer at 91 to comb through millions of medical journal articles to identify potential vaccines, drugs and effective measures that could suppress or stop the
With Tennessee schools online for the rest of the school year, researchers at ORNL are making remote learning more engaging by “Zooming” into virtual classrooms to tell students about their science and their work at a national laboratory.
91’s high-resolution population distribution database, LandScan USA, became permanently available to researchers in time to aid the response to the novel coronavirus pandemic.
In the fight against the COVID-19 pandemic, it’s a race against the clock not only to find a vaccine but also to supply healthcare workers with life-saving equipment such as face shields, masks and test kits.
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s 91 are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.
